Close Menu

Grants

Additional funding opportunities

Research Funding Opportunities

Tools to Find Funding

Grants Awarded for Health Sciences Research

Title Type $ Amount Activity Investigatorsort descending Unit Sponsor Date
CF Learning Network: Implementation Phase Grant $48,496.00 Research Cori Daines Pediatrics Cincinnati Children's Hospital Medical Center 04/2020
Dissemination and Implementation of QT Risk Clinical Decision Support Grant $236,079.00 Research Craig Heise COM Phx Internal Medicine University of Utah 07/2020
Clinical Decision Support System Initiate: Precision Medicine through Pharmacogenomics and Decision Support Grant $1,500,000.00 Research Craig Heise COM Phx Internal Medicine Flinn Foundation 03/2022
PVAHCS IPA -- Lung CA Screening Initiative (VA PI: Samuel Aguayo, MD) Contract $8,000.00 Research Craig Heise COM Phx Internal Medicine Phoenix VA Health Care System 08/2021
Extracranial Carotid Atherosclerosis Contributions to Cognitive Impairment and Alzheimer's Disease Risk Grant $4,900,635.00 Research Craig Weinkauf Surgery National Institute on Aging 09/2021
Evaluation of Peripheral Arterial Disease using the Clarifi Imaging System Contract $65,213.00 Research Craig Weinkauf Surgery Modulated Imaging, Inc 02/2021
Immune Mechanisms of Carotid Plaque Instability Grant $75,000.00 Research Craig Weinkauf Surgery Arizona Biomedical Research Commission 08/2021
Novel in vitro screening platform to accelerate discovery of preclinical drug candidates for cryptosporidiosis Cooperative Agreement $293,949.50 Research Curtis Thorne Cellular & Molecular Medicine University of Dundee (United Kingdom) 05/2022
Bioengineered Prostate-on Chip: Mechanisms of Stromal Dysregulation in Prostate Cancer Grant $2,392,208.00 Research Cynthia Miranti Cellular & Molecular Medicine National Cancer Institute 04/2021
Targeting Bone Metastatic Castration Resistant Prostate Cancer Grant $240,000.00 Research Cynthia Miranti Cellular & Molecular Medicine American Cancer Society 02/2020
Cost Match Account to 4248410 Grant $2,500.00 Instruction Cynthia Standley COM Phx Bioethics Med Humanism Arizona Commission On the Arts 02/2020
A Randomized Phase II Trial of the Altering Intake, Managing Symptoms (AIMS) Intervention for Bowel Dysfunction in Rectal Cancer Survivors Grant $93,773.00 Research Cynthia Thomson Health Promotion Sciences Beckman Research Institute of The City of Hope 02/2022
Catalyzing Communities to Prevent Obesity: A Systems Approach Grant $10,000.00 Other Sponsored Activity Cynthia Thomson Health Promotion Sciences Tufts University 04/2021
Evaluation of Reglagene Compounds in FRET Based Assay with hTERT Promoter DNA Oligomer Sequence Contract $1,240.00 Research - Industry (62.5% MTDC) Daekyu Sun Pharmacology and Toxicology Reglagene, LLC 05/2021
Bedside Exclusion of Pulmonary Embolism in Children Without Radiation (BEEPER) Grant $304,932.00 Research Dale Woolridge Dept of Emergency Medicine Indiana University 02/2021
Neurocognitive and Language Evaluation in the Ato-oxy Treatment for OSA in Children with DS Grant $15,000.00 Research Daniel Combs Pediatrics LuMind Foundation 06/2020
State Office of Rural Health Grant $1,117,050.00 Other Sponsored Activity Daniel Derksen Community Environment & Policy Health Resources and Services Administration 06/2021
Gila River Indian Community COVID-19 Consulting & Contact Tracing Contract $120,000.00 Other Sponsored Activity Daniel Derksen Community Environment & Policy Gila River Indian Community 08/2020
Area Health Education Centers Program COVID Grant $95,455.00 Instruction Daniel Derksen AZ Health Education Centers Health Resources and Services Administration 06/2020
COVID-19 Health Disparities Grant $8,094,106.00 Other Sponsored Activity Daniel Derksen Community Environment & Policy Arizona Department of Health Services 09/2021
Role and Mechanism of Blood Pressure Variability in Risk of Heart Failure Fellowship $202,062.00 Research Training Daniel Nuyujukian Epidemiology and Biostatistics National Heart, Lung, and Blood Institute 01/2021
A Multicenter, Phase 1/2 Study of Selinexor in Combination with Backbone Treatments or Novel Therapies in Patients with Relapsed or Refractory (RR) Diffuse Large B-Cell Lymphoma (DLBCL) Contract $541,268.00 Clinical Trial Daniel Persky Cancer Center Division Karyopharm Therapeutics Inc. 05/2021
A Phase II Trial of PET-Directed Therapy using AVD (doxorubicin, vinblastine, and dacarbazine) plus Brentuximab Vedotin Induction Chemotherapy, with or without Brentuximab Vedotin plus Nivolumab... Contract $40,100.00 Clinical Trial Daniel Persky Cancer Center Division Mayo Foundation for Medical Education and Research (Mayo Clinic) 07/2020
A Phase 2 Open-Label Study of Brentuximab Vedotin in Front-Line Therapy of Hodgkin Lymphoma (HL) and CD30-Expressing Peripheral T-cell Lymphoma (PTCL) in Adults Age 60 and Above Contract $147,691.00 Clinical Trial Daniel Persky Cancer Center Division Seattle Genetics, Incorporated 05/2020
A Three-Arm Study of ME-401 Monotherapy in Subjects with Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) or Follicular Lymphoma (FL), of ME-401 in Combination... Contract $298,700.00 Clinical Trial Daniel Persky Cancer Center Division Clinipace Worldwide 07/2020

Pages